Jun-Zhi Lin

Ms. Jun-Zhi Lin

Hospital of Chengdu University of TCM

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YLYu Liu
Yu Liu
YHYanan He
Yanan He
FWFang Wang
Fang Wang
RXRunchun Xu
Runchun Xu
MYMing Yang
Ming Yang
JLJun-Zhi Lin
Jun-Zhi Lin

1 January 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RYRuifang Yuan
Ruifang Yuan
DZDingkun Zhang
Dingkun Zhang
JYJinhui Yang
Jinhui Yang
ZWZhenfeng Wu
Zhenfeng Wu
CLChuanhong Luo
Chuanhong Luo
MYMing Yang
Ming Yang

30 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
CLChuanhong Luo
Chuanhong Luo
XWXichuan Wei
Xichuan Wei
JSJiao Song
Jiao Song
XXXiaorong Xu
Xiaorong Xu
HHHaozhou Huang
Haozhou Huang
JLJun-Zhi Lin
Jun-Zhi Lin
Fatigue seriously affects people’s work efficiency and quality of life and has become a common health problem in modern societies around the world. The pathophysiology of fatigue is complex and not fully clear. To some degree, interactions between gut microbiota and host may be the cause of fatigue progression. Polyphenols such as tannin, tea polyphenols, curcumin, and soybean isoflavones relieve fatigue significantly. Studies have shown that the gut microbiota is able to convert these active compounds into more active metabolites through intestinal fermentation. However, the mechanism of anti-fatigue polyphenols is currently mainly analyzed from the perspective of antioxidant and anti-inflammatory effects, and changes in gut microbiota are rarely considered. This review focuses on gut microecology and systematically summarizes the latest theoretical and research findings on the interaction of gut microbiota, fatigue, and polyphenols. First, we outline the relationship between gut microbiota and fatigue, including changes in the gut microbiota during fatigue and how they interact with the host. Next, we describe the interactions between the gut microbiota and polyphenols in fatigue treatment (regulation of the gut microbiota by polyphenols and metabolism of polyphenols by the gut microbiota), and how the importance of potential active metabolites (such as urolithin) produced by the decomposition of polyphenols by gut microbiota is emerging. Based on the new perspective of gut microbiota, this review provides interesting insights into the mechanism of polyphenols in fatigue treatment and clarifies the potential of polyphenols as targets for anti-fatigue product development, aiming to provide a useful basis for further research and design.

4 December 2021 in Translational Oncology
Verified
Journal Article
Open access
HLHui-Min Liu
Hui-Min Liu
LMLe-Le Ma
Le-Le Ma
CLChunyu Li
Chunyu Li
BCBo Cao
Bo Cao
YJYifang Jiang
Yifang Jiang
DZDing-kun Zhang
Ding-kun Zhang
According to the 2020 data released by the International Agency for Research on Cancer, breast cancer has surpassed lung cancer as the world's most newly diagnosed first-time cancer. Compared with patients with other types of cancer, those with breast cancer experience greater mental stress and more severe psychological impacts because of the life-threatening diagnosis, physical changes, treatment side effects, and family and social life dysfunctions. These usually manifest as anxiety, depression, nervousness, and insomnia, all of which elicit stress responses. Particularly under chronic stress, the continuous release of neurotransmitters from the neuroendocrine system can have a highly profound impact on the occurrence and prognosis of breast cancer. However, because of the complex mechanisms underlying chronic stress and the variability in individual tolerance, evidence of the role of chronic stress in the occurrence and evolution of breast cancer remains unclear. This article reviewed previous research on the correlation between chronic stress and the occurrence and development of breast cancer, particularly the molecular mechanism through which chronic stress promotes breast cancer via neurotransmitters secreted by the nervous system. We also review the progress in the development of potential drugs or blockers for the treatment of breast cancer by targeting the neuroendocrine system.

4 October 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LMLe-Le Ma
Le-Le Ma
HLHui-Min Liu
Hui-Min Liu
XLXue-Mei Liu
Xue-Mei Liu
XYXiao-Yu Yuan
Xiao-Yu Yuan
CXChao Xu
Chao Xu
DZDing-kun Zhang
Ding-kun Zhang

15 December 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JLJia Li
Jia Li
WCWu Chen
Wu Chen
HLHuimin Liu
Huimin Liu
HLHong Liu
Hong Liu
SXSirui Xiang
Sirui Xiang
CZChuan Zheng
Chuan Zheng